I agree that this site is using cookies. You can find further informations here.
X
Grande, Roberta
149  results:
Search for persons X
?
1

Efficacy of third-line anti-EGFR-based treatment versus reg..:

Salvatore, Lisa ; Bensi, Maria ; Vivolo, Raffaella...
Frontiers in Oncology.  13 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
2

Oligometastatic colorectal cancer: prognosis, role of locor..:

Moretto, Roberto ; Rossini, Daniele ; Zucchelli, Gemma...
European Journal of Cancer.  139 (2020)  - p. 81-89 , 2020
Link: https://doi.org/10.1016/..
 
?
3

Treatment of Metastatic Colorectal Cancer Patients ≥75 Year..:

Grande, Roberta ; Natoli, Clara ; Ciancola, Fabrizio...
PLOS ONE.  11 (2016)  7 - p. e0157751 , 2016
Link: https://doi.org/10.1371/..
 
?
4

Evaluation of Relapse-Free Survival in T3N0 Colon Cancer: T..:

Grande, Roberta ; Corsi, Domenico ; Mancini, Raffaello...
PLoS ONE.  8 (2013)  12 - p. e80188 , 2013
Link: https://doi.org/10.1371/..
 
?
5

Changing monoclonal antibody keeping unaltered the chemothe..:

Grande, Roberta ; Gemma, Donatello ; Sperduti, Isabella...
SpringerPlus.  2 (2013)  1 - p. , 2013
Link: https://doi.org/10.1186/..
 
?
6

Pre-emptive skin toxicity treatment for anti-EGFR drugs: ev..:

Grande, Roberta ; Narducci, Filomena ; Bianchetti, Sara...
Supportive Care in Cancer.  21 (2013)  6 - p. 1691-1695 , 2013
Link: https://doi.org/10.1007/..
 
?
7

Maintenance single-agent bevacizumab or observation after f..:

Moscetti, Luca ; Nelli, Fabrizio ; Fabbri, Maria A...
Investigational New Drugs.  31 (2013)  4 - p. 1035-1043 , 2013
Link: https://doi.org/10.1007/..
 
?
8

Symptom improvement as prognostic factor for survival in ca..:

Narducci, Filomena ; Grande, Roberta ; Mentuccia, Lucia...
Supportive Care in Cancer.  20 (2011)  6 - p. 1221-1226 , 2011
Link: https://doi.org/10.1007/..
 
?
9

Palonosetron plus 3-day aprepitant and dexamethasone to pre..:

Longo, Flavia ; Mansueto, Giovanni ; Lapadula, Vittoria...
Supportive Care in Cancer.  19 (2010)  8 - p. 1159-1164 , 2010
Link: https://doi.org/10.1007/..
 
?
10

Efficacy of third-line anti-EGFR-based treatment versus reg..:

Salvatore, Lisa ; Bensi, Maria ; Vivolo, Raffaella...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9989252/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
11

Upfront FOLFOXIRI plus bevacizumab and reintroduction after..:

Cremolini, Chiara ; Antoniotti, Carlotta ; Rossini, Daniele...
info:eu-repo/semantics/altIdentifier/pmid/32164906.  , 2020
Link: https://hdl.handle.net/2..
 
?
12

Activity and Safety of Cetuximab Plus Modified FOLFOXIRI Fo..:

Cremolini, Chiara ; Antoniotti, Carlotta ; Lonardi, Sara...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5885260/.  , 2018
Link: http://www.ncbi.nlm.nih...
 
?
13

Changing monoclonal antibody keeping unaltered the chemothe..:

Grande, Roberta ; Gemma, Donatello ; Sperduti, Isabella...
http://www.springerplus.com/content/2/1/185.  , 2013
Link: http://www.springerplus...
 
?
14

Efficacy of third-line anti-EGFR-based treatment versus reg..:

Lisa Salvatore ; Maria Bensi ; Raffaella Vivolo...
https://www.frontiersin.org/articles/10.3389/fonc.2023.1125013/full.  , 2023
Link: https://doi.org/10.3389/..
 
?
15

Treatment of Metastatic Colorectal Cancer Patients ≥75 Year..:

Roberta Grande ; Clara Natoli ; Fabrizio Ciancola...
http://europepmc.org/articles/PMC4956101?pdf=render.  , 2016
Link: https://doi.org/10.1371/..
 
1-15